InvestorsHub Logo
Followers 467
Posts 26907
Boards Moderated 2
Alias Born 09/11/2006

Re: surf1944 post# 50

Wednesday, 04/11/2012 9:26:37 AM

Wednesday, April 11, 2012 9:26:37 AM

Post# of 155
Alexion (ALXN), with its only product Soliris, bases its strategy on treating ultra-rare diseases. This company established itself quite quickly on the market where it had no competitor for its niche. Soliris holds a world record for the most expensive medicine. This certainly helps Alexion's incredible earnings growth rate.

http://seekingalpha.com/article/489571-questcor-a-strong-play-in-pharma?source=yahoo


surf's up......crikey